全文获取类型
收费全文 | 230186篇 |
免费 | 21974篇 |
国内免费 | 14983篇 |
专业分类
耳鼻咽喉 | 2030篇 |
儿科学 | 2491篇 |
妇产科学 | 2761篇 |
基础医学 | 25838篇 |
口腔科学 | 4556篇 |
临床医学 | 29678篇 |
内科学 | 31902篇 |
皮肤病学 | 2809篇 |
神经病学 | 11204篇 |
特种医学 | 8816篇 |
外国民族医学 | 112篇 |
外科学 | 24472篇 |
综合类 | 40828篇 |
现状与发展 | 51篇 |
一般理论 | 30篇 |
预防医学 | 16462篇 |
眼科学 | 5586篇 |
药学 | 24725篇 |
240篇 | |
中国医学 | 14315篇 |
肿瘤学 | 18237篇 |
出版年
2024年 | 907篇 |
2023年 | 3550篇 |
2022年 | 9194篇 |
2021年 | 11757篇 |
2020年 | 9104篇 |
2019年 | 7451篇 |
2018年 | 7953篇 |
2017年 | 7463篇 |
2016年 | 6837篇 |
2015年 | 10781篇 |
2014年 | 13353篇 |
2013年 | 12879篇 |
2012年 | 18621篇 |
2011年 | 20101篇 |
2010年 | 13737篇 |
2009年 | 11060篇 |
2008年 | 13574篇 |
2007年 | 12709篇 |
2006年 | 12273篇 |
2005年 | 11490篇 |
2004年 | 7517篇 |
2003年 | 6654篇 |
2002年 | 5476篇 |
2001年 | 4428篇 |
2000年 | 4493篇 |
1999年 | 4350篇 |
1998年 | 2577篇 |
1997年 | 2609篇 |
1996年 | 1953篇 |
1995年 | 1872篇 |
1994年 | 1660篇 |
1993年 | 983篇 |
1992年 | 1343篇 |
1991年 | 1170篇 |
1990年 | 933篇 |
1989年 | 871篇 |
1988年 | 786篇 |
1987年 | 642篇 |
1986年 | 478篇 |
1985年 | 399篇 |
1984年 | 196篇 |
1983年 | 164篇 |
1982年 | 95篇 |
1981年 | 124篇 |
1980年 | 81篇 |
1979年 | 110篇 |
1978年 | 53篇 |
1977年 | 52篇 |
1976年 | 42篇 |
1974年 | 45篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
由于骨盆的特殊结构,其内侧的血管网损伤导致不可压迫性出血。即使创伤中心和救治体系的建设,以及损害控制技术等发展,病死率仍然高达30%~60%。损害控制性复苏、骨盆带、外固定支架、复苏性腹主动脉内球囊阻断(REBOA)、动脉栓塞和腹膜外填塞等技术不断发展,部分已经得到普及,但迄今仍没有公认的确定性止血流程。我国正在普遍建设创伤中心,亟待制订适合我国的骨盆骨折大出血患者的救治流程,以提高救治成功率。本文阐述控制骨盆骨折大出血的外科技术和流程进展供同道参考。 相似文献
42.
目的探讨酪氨酸激酶受体RON及上皮型钙粘蛋白(E-cadherin)在子宫内膜异位症(endometriosis,EMs)上的表达及意义。方法选择2017年7~12月深圳市龙岗区人民医院收治的42例EMs患者,术中分别留取新鲜异位内膜组织和在位内膜组织,随机选取子宫切除或诊断性刮宫治疗的非EMs患者42例,术中留取其正常子宫内膜组织。采用逆转录聚合酶链反应(RT-PCR)检测子宫内膜组织中RON mRNA的表达,采用免疫组织化学方法检测对应42例石蜡组织中RON蛋白和E-cadherin的表达,并分析RON蛋白和E-cadherin的相关性。结果EMs异位内膜组织RON mRNA及RON蛋白阳性表达率显著高于在位内膜组织及正常子宫内膜组织(P<0.001),在位内膜组织及正常内膜组织中E-cadherin阳性表达率显著高于异位内膜组织(P<0.001),且异位内膜组织中RON mRNA及RON蛋白的表达与临床分期有关(P<0.001)。在同一标本中RON蛋白和E-cadherin表达呈负相关关系(r=-0.497,P<0.05)。结论RON的过度表达与EMs的发生发展密切相关,联合检测RON和E-cadherin的异常对判断EMs的发生发展有一定的参考价值,RON可能成为诊断治疗EMs的新靶点。 相似文献
43.
44.
45.
Assessment of Myocardial Infarct Size by Three‐Dimensional and Two‐Dimensional Speckle Tracking Echocardiography: A Comparative Study to Single Photon Emission Computed Tomography 下载免费PDF全文
46.
Chih-Wei Hsu Sheng-Yu Lee Yao-Hsu Yang Liang-Jen Wang 《The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)》2020,23(10):653
BackgroundGeneric antidepressants are approved on the market based on evidence of bioequivalence to their brand-name versions. We aimed to assess whether generic antidepressants exert equal effectiveness as their brand-name counterparts for treating patients with depressive disorders.MethodsIn a nationwide, population-based cohort in Taiwan from 1997 through 2013, patients with a diagnosis of a depressive disorder aged between 18 and 65 years who were new users of antidepressant drugs were classified into either the brand-name group or the generic group. All patients were followed up until medication discontinuation or the end of the study period. We assessed the risk for hospitalization as a primary outcome and augmentation therapy, daily dose, medication discontinuation, or switching to another antidepressant as secondary outcomes.ResultsA total of 277 651 brand-name users (35.8% male; mean age: 41.2 years) and 270 583 generic users (35.8% male; mean age: 41.0 years) were divided into 10 different antidepressant groups (fluoxetine, sertraline, paroxetine, escitalopram, citalopram, venlafaxine, mirtazapine, moclobemide, imipramine, and bupropion). We found that patients treated with the generic form of sertraline, paroxetine, escitalopram, venlafaxine, mirtazapine, and bupropion demonstrated significantly higher risks of psychiatric hospitalization (adjusted hazard ratios ranged from 1.20–2.34), compared to their brand-name counterparts. The differences between brand-name antidepressants and their generic counterparts in secondary outcomes varied across different drugs.ConclusionsCompared to most generic antidepressants, brand-name drugs exhibited more protective effects on psychiatric hospitalization for depressive patients. These findings could serve as an important reference for clinicians when encountering patients with depressive disorder. 相似文献
47.
48.
49.
50.
To evaluate the anthropometric indexes in subjects with varicocele compared to controls and the incidence of varicocele in different body mass index (BMI) groups for the purpose of exploring the association between varicocele and anthropometric indexes. A comprehensive literature search was conducted by using PubMed, MEDLINE, EMBASE databases and Cochrane Library up to February 2019. A systematic review and meta‐analysis was conducted by STATA, and Newcastle–Ottawa Scale was utilised for assessing risk of bias. Ultimately, 13 articles containing seven case–control studies and six cross‐sectional studies with 1,385,630 subjects were involved in our study. Pooled results demonstrated that varicocele patients had a lower BMI (WMD = ?0.77, 95% CI = ?1.03 to ?0.51) and a higher height than nonvaricocele participants, especially in grade 3 varicocele patients. Subgroup analyses showed that normal BMI individuals had a higher risk of varicocele than obese or overweight individuals and a lower risk than underweight individuals. In conclusion, this study indicates that varicocele patients have a lower BMI and a higher height than nonvaricocele participants. Moreover, men with excess bodyweight have a lower incidence of varicocele compared to normal weight or underweight people. That is to say, high BMI and adiposity protect against varicocele and high BMI is associated with a decreased risk of varicocele. 相似文献